Glucose-6-phosphatase catalytic subunit 3 (G6PC3) deficiency associated with autoinflammatory complications

Frontiers in Immunology

Volumn 8, Issue NOV, 2017, Pages

  Mistry, Anoop ^a   Scambler, Thomas ^a   Parry, David ^b   Wood, Mark ^c   Barcenas Morales, Gabriela ^d   Carter, Clive ^a   Doffinger, Rainer ^e   Savic, Sinisa ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Adalimumab; G6PC3; Neutropenia; PID; Systemic autoinflammatory syndromes

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE 6 PHOSPHATASE; IMMUNOGLOBULIN G;

ABDOMINAL PAIN; ARTHRITIS; ARTICLE; AUTOINFLAMMATORY DISEASE; BONE MARROW BIOPSY; CASE REPORT; CHILD; CLINICAL ARTICLE; COLON BIOPSY; ERYTHEMA; ERYTHEMA NODOSUM; FEVER; GENE FREQUENCY; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE DYSREGULATION; INFLAMMATORY BOWEL DISEASE; LAMINA PROPRIA; MALE; MOUTH ULCER; NEUTROPENIA; RASH; SCHOOL CHILD; TERMINAL ILEUM; ULTRASOUND;

EID: 85034024977     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.01485     Document Type: Article

References (23)

1. Martinon F, Aksentijevic I. New players driving inflammation in monogenic autoinflammatory diseases. Nat Rev Rheumatol (2015) 11:11-20. doi:10.1038/nrrheum.2014.158
2. Pathak S, McDermott M, Savic S. Autoinflammatory diseases: update on classification diagnosis and management. J Clin Pathol (2017) 70:1-8. doi:10.1136/jclinpath-2016-203810
3. Boztug K, Appaswamy G, Ashikov A, Schaffer A, Salcer U, Diestelhorst J, et al. A novel syndrome with congenital neutropenia caused by mutation in G6PC3. N Engl J Med (2009) 360:32-43. doi:10.1056/NEJMoa0805051
4. Banka S, Wynn R, Byers H, Arkwright P, Newman W. G6PC3 mutations cause non-syndromic severe congenital neutropenia. Mol Genet Metab (2013) 108:138-41. doi:10.1016/j.ymgme.2012.12.001
5. Desplantes C, Fremond MC, Beaupain B, Harousseau JC, Buzyn A, Pellier I, et al. Clinical spectrum and long-term follow-up of 14 cases with G6PC3 mutations from the French severe congenital neutropenia registry. Orphanet J Rare Dis (2014) 9:183. doi:10.1186/s13023-014-0183-8
6. Banka S, Newman W. A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutations. Orphanet J Rare Dis (2013) 8:84. doi:10.1186/1750-1172-8-84
7. O'Neill LA, Hardie DG. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature (2013) 493:346-55. doi:10.1038/nature11862
8. Vats D, Mukundan L, Odegaard JI, Zhang L, Smith KL, Morel CR, et al. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab (2006) 4:13-24. doi:10.1016/j.cmet.2006.08.006
9. Bégin P, Patey N, Mueller P, Rasquin A, Sirard A, Klein C, et al. Inflammatory bowel disease and T cell lymphopenia in G6PC3 deficiency. J Clin Immunol (2012) 33:520-5. doi:10.1007/s10875-012-9833-6
10. Visser G, Rake JP, Fernandes J, Labrune P, Leonard JV, Moses S, et al. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European study on glycogen storage disease type I. J Pediatr (2000) 137:187-91. doi:10.1067/mpd.2000.105232
11. Dieckgraefe BK, Korzenik JR, Husain A, Dieruf L. Association of glycogen storage disease 1b and Crohn disease: results of a North American survey. Eur J Pediatr (2002) 161:S88-92. doi:10.1007/BF02680002
12. Fata F, Myers P, Addeo J, Grinberg M, Nawabi I, Cappell MS. Cyclic neutropenia in Crohn's ileocolitis: efficacy of granulocyte colony-stimulating factor. J Clin Gastroenterol (1997) 24:253-6. doi:10.1097/00004836-199706000-00015
13. Angelino G, De Angelis P, Faraci S, Rea F, Romeo EF, Torroni F, et al. Inflammatory bowel disease in chronic granulomatous disease: an emerging problem over a twenty years' experience. Pediatr Allergy Immunol (2017). doi:10.1111/pai.12814
14. Korzenik JR, Dieckgraefe BK. Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. Dig Dis Sci (2000) 45:1121-9. doi:10.1023/A:1005541700805
15. McGonagle D, Savic S, McDermott MF. The NLR network and the immunological disease continuum of adaptive and innate immune-mediated inflammation against self. Semin Immunopathol (2007) 3:303-13. doi:10.1007/s00281-007-0084-1
16. Lin SR, Pan C-J, Mansfield B, Chou JY. Functional analysis of mutations in a severe congenital neutropenia syndrome caused by glucose-6-phosphatase-β deficiency. Mol Genet Metab (2015) 114:41-5. doi:10.1016/j.ymgme.2014.11.012
17. Yang Z, Fujii H, Mohan SV, Goronzy JJ, Weyand CM. Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J Exp Med (2013) 210:2119-34. doi:10.1084/jem.20130252
18. Jun HS, Lee YM, Cheung YY, McDermott DH, Murphy PM, De Ravin SS, et al. Lack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-beta-deficient neutrophils in a congenital neutropenia syndrome. Blood (2010) 116:2783-92. doi:10.1182/blood-2009-12-258491
19. Rimessi A, Previati M, Nigro F, Wieckowski MR, Pinton P. Mitochondrial reactive oxygen species and inflammation: molecular mechanisms, diseases and promising therapies. Int J Biochem Cell Biol (2016) 81(Pt B):281-93. doi:10.1016/j.biocel.2016.06.015
20. Rieber N, Hector A, Kuijpers T, Roos D, Hartl D. Current concepts of hyperinflammation in chronic granulomatous disease. Clin Dev Immunol (2012) 2012:252460. doi:10.1155/2012/252460
21. Marks DJ, Miyagi K, Rahman FZ, Novelli M, Bloom SL, Segal AW. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease. Am J Gastroenterol (2009) 104:117-24. doi:10.1038/ajg.2008.72
22. de Luca A, Smeekens SP, Casagrande A, Iannitti R, Conway KL, Gresnigt MS, et al. IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. Proc Natl Acad Sci U S A (2014) 111:3526-31. doi:10.1073/pnas.1322831111
23. Uzel G, Orange JS, Poliak N, Marciano BE, Heller T, Holland SM. Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. Clin Infect Dis (2010) 51:1429-34. doi:10.1086/657308